CIP
EMN icon

Convergence Investment Partners’s Eastman Chemical EMN Stock Holding History

Convergence Investment Partners’s Portfolio EMN Stock Details EMN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-185
Closed -$20K – 494
2018
Q1 		$20K Buy
+185
New +$18.7K ﹤0.01% 592
2015
Q1 		– Sell
-34,255
Closed -$2.6M – 374
2014
Q4 		$2.6M Buy
+34,255
New +$2.71M 0.35% 103

Other funds holding EMN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Convergence Investment Partners's EMN Position: Q2 2018 in Review

Convergence Investment Partners sold out of Eastman Chemical (EMN) in Q2 2018, closing a stake of 185 shares — an estimated $20K sold.

Convergence Investment Partners first reported a position in EMN in Q4 2014 and held it in 2 quarters. The position peaked at $2.6M in Q4 2014. 726 funds tracked by Wall St. Rank hold EMN as of Q2 2018.

  • Convergence Investment Partners reported no remaining Eastman Chemical position as of Q2 2018 after selling out during the quarter.
  • Convergence Investment Partners sold 185 Eastman Chemical shares in Q2 2018, an estimated $20K.
  • Convergence Investment Partners first reported a position in Eastman Chemical in Q4 2014 and held it in 2 quarters.
  • Convergence Investment Partners's Eastman Chemical position peaked at $2.6M in Q4 2014.
  • 726 funds tracked by Wall St. Rank held Eastman Chemical as of Q2 2018.

Based on Convergence Investment Partners's 13F filing for Q2 2018, filed 7 Aug 2018.